Upper Eyelid

Upper Eyelid Related Terms:
Asian Blepharoplasty, Asiandouble Eyelid, Blepharoplasty, Canthoplasty, Cosmetic Surgery, Double Eyelid Surgery, Eyebags Surgery, Eyelash Transplant, Eyelid Ptosis Surgery, Eyelid Surgery Blepharoplasty, Eyelid Surgery, Eyelid Tightening, Eyelid Tuck, Face Procedures, Inside Lower Eyelid, Keratoplasty, Outside Lower Eyelid, Palpebra, Plastic Surgery, Surgeon, Upper Eye Cover, Upper Lid

Plastic Surgery Upper Eyelid Procedure Animation



Surgical rejuvenation of the eyelids or Blepharoplasty is a procedure usually performed on otherwise healthy patients who may have excess skin, muscle, and fat around the eyelids. The operation is done to rejuvenate the eyelids and achieves a more youthful appearance.
Incisions are carefully made along predetermined marks on the skin. These marks are made so the scar will be hidden in natural creases of the skin. Once the incisions are made, the excess skin is removed.
Excess muscle is also carefully removed.
Underneath the muscle, two pockets of fat are exposed. A series of surgical instruments are used to remove the fat.
The incision is closed with small sutures that are usually underneath the skin. The sutures may also be absorbable.
The sutures are usually left in place for three to five days. The patient may have bruising and swelling that will last up to a week or more. Often patients are able to resume fairly normal activities within the first two weeks.


Plastic Surgery Upper Eyelid Procedure Animation
upper eyelid - News update:
According to research published in the Journal of the American Medical Association, there were no significant differences in clinical outcomes between patients receiving sirolimus- and paclitaxel-eluting stents in everyday clinical practice. Researchers evaluated sirolimus- and paclitaxel-eluting stents for the prevention of symptom-driven clinical end points, using a study design reflecting everyday clinical practice. The SORT OUT II trial involved 2098 patients treated with percutaneous coronary intervention (PCI) and randomised to receive either sirolimus-eluting (n = 1065) or paclitaxel-eluting (n = 1033) stents. Indications for PCI included ST-segment elevation myocardial infarction (STEMI), non-STEMI or unstable angina pectoris, and stable angina. Additionally, dual antiplatelet therapy with aspirin and clopidogrel was recommended for 1 year for all patients. After that period, clopidogrel was discontinued and aspirin continued lifelong, if tolerated. The primary end point was a composite clinical end point of major adverse cardiac events, defined as either cardiac death, acute myocardial infarction, target lesion revascularisation, or target vessel revascularisation. Secondary end points were individual components of the composite end point, all-cause mortality and stent thrombosis. The following results were reported: • With respect to the primary end point, the sirolimus- and the paclitaxel-eluting stent groups did not differ significantly in major adverse cardiac events (98 [9.3%] vs. 114 [11.2%]; hazard ratio, 0.83 [95% confidence interval, 0.63-1.08]; P = 0.16) • Additionally, no statistically significant differences were reported in stent thrombosis rates, rates of acute myocardial infarction, target lesion or vessel revascularisation, cardiac death or all-cause death In a related editorial, the authors comment on possible limitations of the study: 1. The study randomised less than a third of the potentially eligible patients, which suggests that the cohort may not be as unselected as the authors had intended for emulating real life practice 2. The study was underpowered due to the small sample size coupled with relatively low event rates More...

Upper Eyelid Sponsored Links

Plastic Surgery Articles


More Upper Eyelid Locations: